Greg Meyers, Executive Vice President and Chief Digital & Technology Officer at Bristol Myers Squibb (BMS) discusses how technology can be leveraged to drive outcomes.

Greg Meyers, Executive Vice President and Chief Digital &amp; Technology Officer at Bristol Myers Squibb (BMS) discusses how technology can be leveraged to drive outcomes.

McKinsey colleagues Alex Devereson and Nav Nagra explore cutting-edge technology trends, tackle pressing industry challenges, and uncover R&D innovations with biopharma leaders. Whether you're a seasoned professional or a curious enthusiast, this series offers valuable insights and thought-provoking discussions that will keep you informed and inspired. Tune in and stay ahead of the curve in the ever-evolving world of biopharma. 

McKinsey colleagues Alex Devereson and Nav Nagra explore cutting-edge technology trends, tackle pressing industry challenges, and uncover R&amp;D innovations with biopharma leaders. Whether you're a seasoned professional or a curious enthusiast, this series offers valuable insights and thought-provoking discussions that will keep you informed and inspired. Tune in and stay ahead of the curve in the ever-evolving world of biopharma.

Eureka!

McKinsey colleagues Alex Devereson and Nav Nagra explore cutting-edge technology trends, tackle pressing industry challenges, and uncover R&D innovations with biopharma leaders. Whether you're a seasoned professional or a curious enthusiast, this series offers valuable insights and thought-provoking discussions that will keep you informed and inspired. Tune in and stay ahead of the curve in the ever-evolving world of biopharma.

McKinsey colleagues Alex Devereson and Nav Nagra explore cutting-edge technology trends, tackle pressing industry challenges, and uncover R&amp;D innovations with biopharma leaders. Whether you're a seasoned professional or a curious enthusiast, this series offers valuable insights and thought-provoking discussions that will keep you informed and inspired. Tune in and stay ahead of the curve in the ever-evolving world of biopharma.

Bristol Myers Squibb CDTO Greg Meyers on biopharma’s AI-enabled future

Lykke Hinsch Gylvin shares how Boehringer Ingelheim’s innovative clinical trial designs bring therapies to patients faster.

Lykke Hinsch Gylvin shares how Boehringer Ingelheim&rsquo;s innovative clinical trial designs bring therapies to patients faster.

Lykke Hinsch Gylvin on the cutting edge of clinical trial design

John Marioni discusses how he and his teams across industries and academia use evolving technologies to bring sophisticated drug therapies to patients.

John Marioni discusses how he and his teams across industries and academia use evolving technologies to bring sophisticated drug therapies to patients.

Genentech’s John Marioni on enhancing drug discovery with data and AI

In this episode of Eureka!, a McKinsey podcast on innovation in life sciences R&D, hosts Navraj Nagra, Alex Devereson, and Meredith Langstaff speak to Ashita Batavia, head of hematology and oncology data sciences, R&D, at Johnson & Johnson Innovative Medicine (J&J). They discuss how real-world data can better inform clinical trials, the shifts in mindsets and capabilities needed to support AI in biopharma, and how to navigate the complexity of clinical trials with more-pragmatic trial designs.

In this episode of Eureka!, a McKinsey podcast on innovation in life sciences R&amp;D, hosts Navraj Nagra, Alex Devereson, and Meredith Langstaff speak to Ashita Batavia, head of hematology and oncology data sciences, R&amp;D, at Johnson &amp; Johnson Innovative Medicine (J&amp;J). They discuss how real-world data can better inform clinical trials, the shifts in mindsets and capabilities needed to support AI in biopharma, and how to navigate the complexity of clinical trials with more-pragmatic trial designs.

Bristol Myers Squibb CDTO Greg Meyers on biopharma’s AI-enabled future

Eureka!

In 1 playlist(s)

Eureka!

Social links

Follow podcast

Recent clips